Press release
Pentavalent Market 2024 Report By Key Companies, Regional Analysis And Forecast 2033
Pentavalent Market
The Business Research Company offers in-depth market insights through Pentavalent Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The pentavalent market size has grown steadily in recent years. It will grow from $2.53 billion in 2023 to $2.65 billion in 2024 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to global immunization initiatives, government vaccination programs, prevention of multiple diseases, public health awareness, international partnerships and funding.
The pentavalent market size is expected to see steady growth in the next few years. It will grow to $3.17 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to continued global immunization efforts, expansion of vaccination programs, introduction in new geographies, research and development initiatives, collaborations for vaccine access. Major trends in the forecast period include global health initiatives and funding support, public awareness and education campaigns, government policies and regulatory frameworks, technological innovations in vaccine manufacturing.
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=9104&type=smp
Market Segmentation:
The pentavalent market covered in this report is segmented -
1) By Type: Sodium Stibogluconate, Meglumine Antimoniate
2) By Formulation Type: Lyophilized, Liquid
3) By Application: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies
Major Driver - Pentavalent Market Surges With Increasing Diphtheria Incidence
The rising prevalence of diphtheria is expected to boost the growth of the pentavalent market going forward. Corynebacterium diphtheriae is a bacterium that causes the severe, extremely contagious disease known as diphtheria. Diphtheria causes severe difficulties with eating and breathing, as well as the possibility of skin ulcers. The pentavalent vaccine protects children from Diphtheria diseases by a pentavalent immunization in a 3-dose schedule, as a result, the rising prevalence of diphtheria increased the demand for pentavalent vaccines. For instance, in 2022, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, an unusually high number of reported cases of diphtheria were recorded through the International Health Regulations (IHR) reporting process, primarily in the months of June and August 2022. Seven nations have documented 144 instances of diphtheria, many of which were among asylum seekers. Among 144 patients, 97 (69%) were determined to be clinically compatible, 44 (31%) to be toxigenic diphtheria cases by laboratory confirmation, and 3 (2%) were suspected cases. Therefore, the rising prevalence of diphtheria is driving the growth of the pentavalent market.
Competitive Landscape:
Major companies operating in the pentavalent market report are Pfizer Inc., Merck & Co Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, LG Chem Ltd., GlaxoSmithKline plc, Shandong Xinhua Pharmaceutical Company Limited, Mitsubishi Tanabe Pharma Corporation, PT Bio Farma (Persero), Shantha Biotechnics Limited, Seqirus Holdings plc, Biological E. Limited, Serum Institute of India Private Limited, Indian Immunologicals Limited, Incepta Pharmaceuticals Limited, Shanghai Institute of Biological Products Co Ltd., Changchun Changsheng Biotechnology Co Ltd., Adimmune Corporation, AJ Vaccines, Albert David Limited, Biogenics Pvt Ltd., GreenSignal Bio Pharma Limited, PanGen Biotech Inc., Biomed Pvt Ltd., Maiden Pharmaceuticals Limited, Panacea Drugs Limited, Crucell N.V., Bharat Biotech International Limited, Vacsera Ltd., Vacunas Finlay S.A., Pasteur Institute of India, Zydus Cadila Healthcare Limited, EuBiologics Co Ltd.
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/pentavalent-global-market-report
Top Trend - Companies Spearhead Innovation With Pentavalent Immunization Solutions
Major companies operating in the pentavalent market are focused on developing innovative solutions such as pentavalent immunization vaccines. Pentavalent immunization vaccines are a type of combination vaccine designed to protect against five different diseases. For instance, in October 2023, Pfizer, a US-based pharmaceutical company announced the FDA approval for its 'Penbraya' pentavalent vaccine. It is the initial and sole pentavalent vaccine providing protection against the five most prevalent meningococcal serogroups-A, B, C, W-135, and Y-in individuals aged 10 through 25 years. The vaccine merges elements from the Trumenba meningococcal group B vaccine and the Nimenrix meningococcal groups A, C, W-135, and Y conjugate vaccine. Penbraya has been identified as effective in providing protection against the five meningococcal serogroups responsible for the majority of global cases of invasive meningococcal disease.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Pentavalent Market Characteristics
3. Pentavalent Market Trends And Strategies
4. Pentavalent Market - Macro Economic Scenario
5. Pentavalent Market Size And Growth
…..
27. Pentavalent Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pentavalent Market 2024 Report By Key Companies, Regional Analysis And Forecast 2033 here
News-ID: 3418901 • Views: …
More Releases from The Business research company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Pentavalent
Pentavalent Vaccine Market: A Comprehensive Overview of the Industry's Players a …
► Global Pentavalent Vaccine Market size was valued at USD 2.73 Bn. in 2024 and the total Pentavalent Vaccine Market revenue is expected to grow by 3.3% from 2025 to 2032, reaching nearly USD 3.54 Bn.
The pentavalent vaccine market is evolving as global healthcare systems increasingly prioritize comprehensive immunization programs to protect children from multiple infectious diseases with a single shot. This vaccine, which combines protection against diphtheria, tetanus, pertussis,…
Fully Liquid Pentavalent Vaccine Market Outlook and Future Projections for 2030
The fully liquid pentavalent vaccine market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines…
Key Trend Reshaping the Pentavalent Market in 2025: Key Companies Drive Growth T …
Which drivers are expected to have the greatest impact on the over the pentavalent market's growth?
The steady increase in the occurrence of diphtheria is projected to foster the pentavalent market's expansion. Corynebacterium diphtheriae is a bacterial strain responsible for the highly communicable and severe disease known as diphtheria. This disease can cause serious issues with eating and breathing, and could potentially result in skin ulcers. The pentavalent vaccine offers protection…
Fully Liquid Pentavalent Vaccine Market Outlook and Future Projections for 2030
The fully liquid pentavalent vaccine market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines…
Pentavalent Market Size, Share, Growth Analysis, Forecast and Report 2024-2033
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033
The Business Research Company presents an extensive market research report on the Pentavalent Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.
Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities, providing…
Pentavalent Vaccine Market Future Scope, Industry Insight, Revenue Analysis and …
Pentavalent Vaccine Market revenue is expected to grow at a CAGR of 3.3% through 2023 to 2029, reaching nearly USD 3.21 Bn.
Pentavalent Vaccine Market Report Scope and Research Methodology
Forecasting the market until 2029 is based on real-time output, considering data from 2022 and estimations derived from key players' disclosures. The projections take into account actual numbers from 2018 to 2022, incorporating the impact of global lockdowns in 2020 and 2021…
